Multimmune Gmb News Today

/PRNewswire/ -- Data Bridge Market Research completed a qualitative study titled "Natural Killer (NK) Cell Therapeutics Market" with 100+ market data tables,...

Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide February 04, 2021 11:35 ET | Source: Alphageneron Pharmaceuticals Alphageneron Pharmaceuticals Cambridge, Massachusetts, UNITED STATES CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive License Agreement with Multimmune GmbH, of Munich, Germany,...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For ... Alphageneron PharmaceuticalsFebruary 4, 2021 GMT CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive License Agreement with Multimmune GmbH, of Munich, Germany, (Multimmune) on October 1st, 2020, for its clinical stage autologous Natural Ki...